Updated Jul 16, 2026
Barber Daniel has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.45M.

Daniel Barber is the President and CEO of Aquestive Therapeutics, Inc., a specialty pharmaceutical company focused on developing products for medical needs, particularly in the Central Nervous System. He has been involved in the company's strategic direction and product development efforts.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-16 | AQST | Aquestive Therapeutics, Inc. | S — Open-market sale | 25.0K | $4.16 | $104K |
| 2026-05-18 | AQST | Aquestive Therapeutics, Inc. | S — Open-market sale | 8.3K | $4.29 | $35K |
| 2026-05-07 | AQST | Aquestive Therapeutics, Inc. | F — Tax withholding / forfeiture | 335.9K | $4.18 | $1.40M |
| 2026-03-11 | AQST | Aquestive Therapeutics, Inc. | S — Open-market sale | 180.7K | $4.17 | $754K |
| 2026-03-11 | AQST | Aquestive Therapeutics, Inc. | A — Grant or award | 262.0K | $0.00 | |
| 2025-09-26 | AQST | Aquestive Therapeutics, Inc. | S — Open-market sale | 91.3K | $6.03 | $551K |
| 2025-09-19 | AQST | Aquestive Therapeutics, Inc. | S — Open-market sale | 400 | $6.00 | $2K |
Daniel Barber is the President and CEO of Aquestive Therapeutics, Inc., a specialty pharmaceutical company focused on developing products for medical needs, particularly in the Central Nervous System. He has been involved in the company's strategic direction and product development efforts.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($1.45M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Barber Daniel profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.